Lecture 2.2 - The Innate Immune System PDF
Document Details
Uploaded by airafatz
Aston University
Tags
Summary
This lecture details the innate immune system, focusing on factors influencing the host-pathogen relationship and various clinical issues arising from disruptions within these interactions. It explores the role of the immune system in countering pathogens, innate barriers, and the complement system.
Full Transcript
Factors determining the outcome of host-pathogen relationship: Key definitions: ◦Immune system - cells and organs that contribute to immune defences against infectious and non-infectious conditions (self vs non-self) ◦Infectious disease - when the pathogen succeeds in evading and/or ove...
Factors determining the outcome of host-pathogen relationship: Key definitions: ◦Immune system - cells and organs that contribute to immune defences against infectious and non-infectious conditions (self vs non-self) ◦Infectious disease - when the pathogen succeeds in evading and/or overwhelming the host’s immune defences Roles of the immune system: The immune response: The innate barriers: Innate barriers - microbiota (commensals): ◦The skin: ‣ Staphylococcus aureus ‣ Staphylococcus epidermis ‣ Streptococcus pyogenes ‣ Candida albicans ◦The nasopharynx: ‣ Streptococcus pneumoniae ‣ Neisseria meningitidis ‣ Haemophilus species ◦All can become pathogenic Clinical problems start when: ◦Normal flora is displaced from its normal location to sterile location. ◦Breaching the skin integrity: ‣ Skin loss (burns) ‣ IV lines ‣ Surgery ‣ Skin diseases ‣ Injection drug users ‣ Tattooing/body piercing ◦Fecal-oral route ‣ Foodborne infection ◦Fecal-perineal-urethral route ‣ Urinary tract infection (women) ◦Poor dental hygiene/dental work ‣ Dental extraction ‣ Gingivitis ‣ Brushing/flossing - common cause of harmless bacteraemia ◦Serious infections in high risk patients ‣ Asplenic (and hyposplenic) patients ‣ Patients with damaged or prosthetic valves ‣ Patients with previous infective endocarditis ‣ -> Prevention and advice to patients (NICE) ◦Normal flora overgrown and becomes pathogenic when host becomes immune-compromised ‣ Diabetes ‣ AIDS (not an infection) ‣ Malignant diseases ‣ Chemotherapy (Muscositis) ◦When normal flora in mucosal surfaces is depleted by antibiotic therapy: ‣ Intestine -> severe colitis (Clostridium difficile) ‣ Vagina -> thrush (Candida albicans) The immune response: Initial immune response: ◦The initial immune response occurs if the pathogen overcomes the innate barriers and enters the body. ‣ Macrophages have pattern recognition receptors (PRRs) on their surface which recognise the pathogen associated molecular patterns (PAMPs) on an invading pathogen and phagocytosed them. ‣ Macrophages release cytokines which recruit other cells to the site of infection, for example monocytes (precursors of macrophages) and neutrophils ‣ Cytokines also have other functions including causing inflammation Cytokines cause inflammation which results in: ◦Vasodilation ◦Vascular permeability ◦Mast cell degranulation ◦Clotting system Microbes: PRRs and PAMPs: Interaction between microbial PAMPs and their PRRs in innate cells: Action of macrophage, monocyte, neutrophils and other cell-derived cytokines such as TNF alpha, IL-1, IL-6 and IL-8: ◦Systemic actions: ‣ Liver: C reactive protein (CRP) acts as opsonin (IL_6) Mannose binding lectin (MBL -> complement activation) ‣ Blood vessels: Neutrophil recruitment (IL-8) ‣ Hypothalamus: Increased body temperature (IL-1) ◦Local inflammatory actions: ‣ Blood vessels Vasodilation Vascular permeability ◦NOTE: TNF alpha reactive which is also released from these cells can do all of the above. Initial immune response: ◦Dendritic cells phagocytose and travel in the blood or the lymphatic system to present the antigen from the pathogen to the T and B cells which initiates the specific adaptive immune response. ◦The presence of the pathogen leads to the activation of the complement system via the lectin pathway or the alternative pathway. The complement system: ◦Complement pathways ◦20 serum proteins ◦Most important C1-C9 ◦3 activating pathways ‣ Classical pathway Initiated by antibody-antigen Reaction (membrane attack complex) ‣ Alternative pathway Initiated by cell surface microbial Constituents (endotoxins on E.coli) ‣ Mannose binding lectin pathway Initiated when MBL binds to mannose-containing residues of proteins found on many microbes (Salmonella spp.) Candida albicans Main phagocytes: Other key cells of innate immunity: Microbes: Examples of opsonins: ◦Complement proteins: ‣ C3 ‣ C4 ◦Antibodies ‣ IgG ‣ IgM ◦Acute phase proteins ‣ C-reactive protein (CRP) ‣ Mannose-binding lectin (MBL) ◦-> Essential in clearing encapsulated bacteria: ‣ Neisseria meningitidis ‣ Streptococcus pneumoniae ‣ Haemophilus influenza b Clearance of opsonised pathogen: ◦Complement can “punch holes” in the cell membrane of the pathogen leading to death. ◦Phagocytes such as macrophages and neutrophils have Fc receptors on their surface which bind to the Fc region of an antibody which has formed a complex with an antigen. ‣ This leads to internalisation of the pathogen which has been coated in antibody ‣ The macrophage produces reactive oxygen species to destroy the pathogen Phagocytosis: killing of pathogens: Phagocyte intracellular killing mechanisms: ◦Oxygen-dependent pathway (respiratory burst) ‣ Toxic O2 products for the pathogens: Hydrogen peroxide, Hydroxyl radical, Nitric oxide, Singlet oxygen, Hypohalite ◦Oxygen-independent pathways: ‣ Lysozyme ‣ Lactoferrin or transferrin ‣ Cationic proteins (cathepsin) ‣ Proteolytic and hydrolytic enzymes ‣ NETs (neutrophil extracellular traps) NETosis: ◦The process by which neutrophils externally trap pathogens ‣ Release of decondensed chromatin and granule contents into the extracellular space ◦Can be used as a mechanism of neutrophil cell death ◦Commonly used to deal with pathogenic insult Summary of the innate immune response: The innate immune response: Clinical problems start when phagocytosis is reduced: ◦Decrease spleen function ‣ Asplenic patients (no spleen) ‣ Hyposplenic patients (reduced spleen function) ◦Decrease neutrophil number (